An image showing coronavirus particles

Green light for world’s first Sars-CoV-2 studies that will infect healthy volunteers

2021-02-24T09:30:00+00:00

UK trials will assess how well Covid-19 treatments work and if vaccines protect against new virus variants

An image showing coronavirus an antibodies

Coronavirus variants stymie success of monoclonal antibodies

2021-02-23T15:50:00+00:00

Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail

An image showing Pfizer/BioNtech's Covid vaccine

A rough guide to pharma partnership deals

2021-02-09T09:34:00+00:00

Coronavirus vaccines are driving unusual collaborations with a range of benefits

The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics

Introduction: the coronavirus pandemic and the future

This series of Chemistry World reports is part of a forth coming e-book and hardback to be published by the Royal Society of Chemistry. The book was motivated by a desire on the part of the editors and the authors to produce a body of information on the new and deadly coronavirus about which the world was largely uninformed and for which it was totally unprepared. 

Shinagawa station in busy morning rush hour

Favipiravir

2020-07-31T22:10:00+01:00By

Originally developed to treat flu and marketed in Japan as Avigan, promising Covid-19 trial results have seen countries stockpiling this medication by the millions

Source:  © StreetVJ / Shutterstock.com